Company profile for Oramed Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Oramed Pharmaceuticals (NASDAQ: ORMP) was established in 2006, and has developed a unique proprietary platform technology that allows for the oral delivery of drugs presently administered only via injection. Oramed has an experienced management team with many years of business and pharmaceutical experience, and is backed by world-class scientific experts. From the company’s inception, Oramed has successfully tested its...
Oramed Pharmaceuticals (NASDAQ: ORMP) was established in 2006, and has developed a unique proprietary platform technology that allows for the oral delivery of drugs presently administered only via injection. Oramed has an experienced management team with many years of business and pharmaceutical experience, and is backed by world-class scientific experts. From the company’s inception, Oramed has successfully tested its technology via various animal and human studies on its two flagship products, an orally ingestible insulin capsule, ORMD-0801, and an oral GLP-1 analog (exenatide) capsule, ORMD-0901.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Suite 228, 1185 Avenue of the Americas New York, NY 10036
Telephone
Telephone
+18449ORAMED
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/oramed-pharmaceuticals-inc-declares-dividend-distribution-of-common-stock-purchase-rights-302617147.html

PR NEWSWIRE
17 Nov 2025

https://www.prnewswire.com/news-releases/oramed-reports-fiscal-third-quarter-2025-financial-results-302617174.html

PR NEWSWIRE
17 Nov 2025

https://www.prnewswire.com/news-releases/oramed-releases-letter-to-shareholders-highlighting-developments-in-its-oral-insulin-program-significant-investment-appreciation-and-upcoming-growth-initiatives-302592812.html

PR NEWSWIRE
23 Oct 2025

https://www.globenewswire.com/news-release/2025/10/01/3159560/0/en/Scilex-Holding-Company-Announces-the-Completion-of-the-First-Tranche-of-the-Oramed-Pharmaceuticals-Inc-Warrant-Repurchase.html

GLOBENEWSWIRE
01 Oct 2025

https://www.globenewswire.com/news-release/2025/04/28/3069246/0/en/Alpha-Tau-Announces-Closing-of-36-9-Million-Registered-Direct-Offering-and-Strategic-Marketing-Alliance-with-Oramed-Pharmaceuticals.html

GLOBENEWSWIRE
28 Apr 2025

https://www.prnewswire.com/news-releases/oramed-pharmaceuticals-announces-36-9-million-investment-and-strategic-collaboration-with-alpha-tau-medical-302439636.html

PR NEWSWIRE
28 Apr 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty